##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Dec 28, 2021

Xiang Xiao

Huan Deng

Mumba Mulutula Chilufya

Yizhen Lv

Yan Zhao

Jiaxin Liu

Ziwei Guo

Lichun Qiao

Jing Han  

Dong Wang

Chengjuan Qu

Abstract

Paper link corrected: https://bonoi.org/index.php/si/article/view/636


It has been brought to authors attention that there is a missing part in “Materials and Methods” of the Systematic Review article by Xiao et al., entitled “Chondroitin Sulfate and Hyaluronic Acid Perfusion for Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis” in the Volume 39, No. 4 of Science Insights (pp.363-373).


The missing part of the “Materials and Methods” is as below:


Population: Patients with IC/BPS.
Intervention: All patients underwent intravesical HA and/or CS treatment regimen.
Comparison: Improvement in symptoms pre-treatment and post-treatment or other treatment regimen.
Outcome: The primary outcome was the change in visual analogue scale (VAS) for pain symptom from baseline to the follow-up period; secondary outcomes were the changes in total scores of the O’Leary-Sant Interstitial Cystitis Symptom Index (ICSI) and Problem Index (ICPI), storage symptoms including frequency and urgency, and bladder capacity.

##plugins.themes.bootstrap3.article.details##

Keywords
Supporting Agencies

This work was funded by the National Natural Science Foundation of China (#81872567).

References
How to Cite
Xiao, X., Deng, H., Chilufya, M. M., Lv, Y., Zhao, Y., Liu, J., Guo, Z., Qiao, L., Han, J., Wang, D., & Qu, C. (2021). Erratum: Chondroitin Sulfate and Hyaluronic Acid Perfusion for Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis. Science Insights, 39(5), 419. https://doi.org/10.15354/si.21.er001
Section
Erratum